Injection therapy in knee osteoarthritis: cortisol, hyaluronic acid, PRP, or BMAC (mesenchymal stem cell therapy)?

Publikation: Beitrag in Fachzeitschrift (peer-reviewed) › Artikel in Fachzeitschrift

5 Zitate (Scopus)

Zugriff auf Dokument

@article{f27fd067242b455daddd5d9fff55d65c,

title = "Injection therapy in knee osteoarthritis: cortisol, hyaluronic acid, PRP, or BMAC (mesenchymal stem cell therapy)?",

author = "Christof Pabinger and Kobinia, \{Georg Stefan\} and Dietmar Dammerer",

year = "2024",

month = sep,

doi = "10.3389/fmed.2024.1463997",

language = "English",

volume = "11",

pages = "1463997",

journal = "Frontiers in Medicine",

issn = "2296-858X",

publisher = "Frontiers Media S.A.",

}

TY - JOUR

T1 - Injection therapy in knee osteoarthritis

T2 - cortisol, hyaluronic acid, PRP, or BMAC (mesenchymal stem cell therapy)?

AU - Pabinger, Christof

AU - Kobinia, Georg Stefan

AU - Dammerer, Dietmar

PY - 2024/9

Y1 - 2024/9

UR - https://www.scopus.com/pages/publications/85206380770

U2 - 10.3389/fmed.2024.1463997

DO - 10.3389/fmed.2024.1463997

M3 - Journal article

C2 - 39399118

SN - 2296-858X

VL - 11

SP - 1463997

JO - Frontiers in Medicine

JF - Frontiers in Medicine

M1 - 1463997

ER -